Literature DB >> 7954343

Transformation linked decrease of pyruvate dehydrogenase complex in human epidermis.

M L Eboli1, A Pasquini.   

Abstract

Epidermis exhibits glycolytic features peculiar to cancer cells. The activity of pyruvate dehydrogenase complex, both active (PDHa) and total (PDHt) forms, has been investigated and compared in epidermis and epidermal carcinomas from human source. Low or undetectable PDHa is found in either normal and neoplastic tissue. PDHt is unchanged in human epidermis between the second and seventh decades of life but is dramatically decreased following neoplastic transformation (0.107 and 0.026 units/g fresh tissue for epidermis and epidermal carcinoma, respectively). As PDH plays a key role in mitochondrial carbohydrate metabolism, the decrease of total enzymic capacity found in tumors suggest that different mechanisms regulate PDH expression and, in turn, glycolytic mechanisms of epidermis and cancer cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954343     DOI: 10.1016/0304-3835(94)90281-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

2.  The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer.

Authors:  Yongxian Zhuang; Reynold C Ly; Carleigh V Frazier; Jia Yu; Sisi Qin; Xiao-Yang Fan; Matthew P Goetz; Judy C Boughey; Richard Weinshilboum; Liewei Wang
Journal:  Cancer Metab       Date:  2019-01-24

3.  PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.

Authors:  S M Wigfield; S C Winter; A Giatromanolaki; J Taylor; M L Koukourakis; A L Harris
Journal:  Br J Cancer       Date:  2008-06-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.